Bile reflux gastritis, i.e., bile reflux gastritis, is rarely cancerous in general, and even if it is to be cancerous, it needs to go through a long period of time and undergo the stages of precancerous lesions such as gastric mucosal atrophy and intestinal metaplasia, etc., before cancerous transformation occurs.
Bile reflux gastritis is a disease in which the gastric mucosa is damaged due to the reflux of bile from the duodenum into the stomach. When bile reflux is heavy, gastric ulcer, gastric bleeding and other diseases may occur. Long-term reflux can lead to chronic inflammation of gastric mucosa, and then gastric mucosa gradually undergoes atrophy, intestinal epithelial hyperplasia and atypical hyperplasia, which belong to pre-cancerous lesions.
Pre-cancerous lesion is a pre-condition in the process of cancer occurrence and development, but it is not cancer, and pre-cancerous lesion may not necessarily evolve into cancer. If bile reflux gastritis is detected on examination, it can be treated with medications such as magnesium aluminum carbonate, domperidone, ursodeoxycholic acid, etc. under the guidance of a medical professional. Without active intervention, cancer can develop within a few years or a decade.